Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/2010
02/09/2010CA2341011C Induced aggregation and agglutination of platelets
02/09/2010CA2300096C Methods and compositions for generating chemiluminescence with peroxidase enzymes
02/09/2010CA2256532C Immunodominant 120 kda surface-exposed adhesion protein genes of ehrlichia chaffeensis
02/09/2010CA2250212C Device and method for multiple analyte detection
02/07/2010CA2670835A1 Method for identifying small rnas
02/07/2010CA2636427A1 Method for identifying small rnas
02/04/2010WO2010014978A1 Determination of circulating 1alpha, 25 (oh) 2d3 by enzyme electrode
02/04/2010WO2010014975A2 Use of microrna signatures for assessing risk levels of neuroblastoma patients
02/04/2010WO2010014920A1 Circulating mutant dna to assess tumor dynamics
02/04/2010WO2010014905A2 Polymorphisms associated with inflammatory bowel disease
02/04/2010WO2010014820A2 Particles for use in supported nucleic acid ligation and detection sequencing
02/04/2010WO2010014755A1 Methods and compounds for enhancing anti-cancer therapy
02/04/2010WO2010014740A2 Eg82013 and eg81345 nucleic acids and uses thereof
02/04/2010WO2010014672A1 Method for evaluating the virulence of pathogenic biphasic bacteria
02/04/2010WO2010014651A1 Pharmacogenetic markers for susceptibility to drug-induced pancreatic toxicity
02/04/2010WO2010014643A1 Irak-1 as regulator of diseases and disorders
02/04/2010WO2010014636A1 Methods for identifying rna segments bound by rna-binding proteins or ribonucleoprotein complexes
02/04/2010WO2010014588A1 Stimulus-elicited genomic profile markers of alzheimer's disease
02/04/2010WO2010014582A2 Brm expression and related diagnostics
02/04/2010WO2010014330A2 Method and apparatus for determining the yield of at least one component
02/04/2010WO2010014235A1 System and methods for determining molecules using mass spectrometry and related techniques
02/04/2010WO2010014222A1 Compositions for detecting cell death and methods of use thereof
02/04/2010WO2010014043A1 Methods of preventing, arresting or reversing tumourigenesis and of identifying compounds capable of the same
02/04/2010WO2010014000A1 Susceptibility markers for multiple sclerosis
02/04/2010WO2010013855A1 Biomarker for diagnosis of aspirin hypersensitivity, method for manufacturing the same, and method for diagnosis of aspirin hypersensitivity using the same
02/04/2010WO2010013842A1 Method for detecting chromosome deficiencies for congenital abnormality
02/04/2010WO2010013830A1 Nucleic acid occurring in blood from hepatitis patient, polypeptide encoded by the nucleic acid, and use of the same
02/04/2010WO2010013771A1 Universal nucleic acid probe set and method for utilization thereof
02/04/2010WO2010013678A1 Reagent for detecting abnormal cell in cervix of uterus, and method for detecting abnormal cell in cervix of uterus by using same
02/04/2010WO2010013633A1 Methods for prediction of rb status and sensitivity to plk1 inhibitor of cell
02/04/2010WO2010013485A1 Melk epitope peptides and vaccines containing the same
02/04/2010WO2010013317A1 Nucleic acid probe set and method of using the same
02/04/2010WO2010013138A2 Methods and compositions for detection of a pathogen, disease, medical condition, or biomarker thereof
02/04/2010WO2010013071A2 Methods concerning ppar delta and antagonists thereof
02/04/2010WO2010013038A2 Novel methods of differentiating yeast strains and/or determining genetic stability of yeast strains, and uses thereof
02/04/2010WO2010013017A1 Multiplex amplification and detection
02/04/2010WO2010012948A2 Combination of two genetic elements for controlling the floral development of a dicotyledonous plant, and use in detection and selection methods
02/04/2010WO2010012823A1 Prediction method for the screening, prognosis, diagnosis or therapeutic response of prostate cancer, and device for implementing said method
02/04/2010WO2010012690A1 A genetic marker test for brachyspina and fertility in cattle
02/04/2010WO2010012476A2 Genetic variations associated with feather pecking behaviour in avians
02/04/2010WO2010012464A1 Improved lysis and reverse transcription for mrna quantification
02/04/2010WO2010012086A1 Methods and compositions for determining severity of heart failure in a subject
02/04/2010WO2010012077A1 Compositions, methods and kits for reprogramming somatic cells
02/04/2010WO2010012074A1 Nucleotide sequence encoding an alcohol dehydrogenase from artemisia annua and uses thereof
02/04/2010WO2010012063A1 Method of detecting bioactive molecules in a fluid sample
02/04/2010WO2009151742A3 Methods for identifying nuclear receptor/ligand combinations for targeting brain tumor stem cells
02/04/2010WO2009150517A3 A method for identifying scaffold/matrix attachment region (s/mar) sequence
02/04/2010WO2009132308A3 Methods of identifying agents that promote axonal development
02/04/2010WO2009114321A3 Rationally-designed meganucleases for maize genome engineering
02/04/2010WO2009105549A3 Detection and prognosis of lung cancer
02/04/2010WO2009019260A3 Use of tlr-2 antagonists for treatment of reperfusion injury and tissue damage
02/04/2010WO2009016180A3 Peptide imaging agents
02/04/2010WO2009012343A9 Arrays, substrates, devices, methods and systems for detecting target molecules
02/04/2010WO2008084477A3 In-situ filter
02/04/2010WO2006089087A9 Compositions, kits and methods for identification, assessment, prevention and therapy of cancer
02/04/2010WO2006076641A3 Methods and compositions for preventing and treating a disease related to glycan dysregulation
02/04/2010WO2004016219A9 Clinical assays for the detection and typing of human herpesviruses
02/04/2010WO2003072064A9 Methods and compositions for regulating adipogenesis
02/04/2010WO2003063798A9 Compositions and methods for treatment of infectious and inflammatory diseases
02/04/2010WO2003014319A9 Polymorphisms associated with multiple sclerosis
02/04/2010US20100031397 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
02/04/2010US20100031386 Sweet pepper line sby28-1223
02/04/2010US20100031385 Spinach line msa66-1119m
02/04/2010US20100031384 Spinach line smb66-1114f
02/04/2010US20100031383 Spinach line ssb66-1092m
02/04/2010US20100031382 Spinach line ssb66-1087f
02/04/2010US20100031381 Spinach line smb66-1086m
02/04/2010US20100031380 Identification of chilling-resistant plants
02/04/2010US20100031378 Novel gene disruptions, compositions and methods relating thereto
02/04/2010US20100030208 Method for Ablation Volume Determination and Geometric Reconstruction
02/04/2010US20100030051 Subcutaneous Glucose Electrode
02/04/2010US20100030050 Subcutaneous Glucose Electrode
02/04/2010US20100030049 Subcutaneous Glucose Electrode
02/04/2010US20100030048 Subcutaneous Glucose Electrode
02/04/2010US20100030047 Subcutaneous Glucose Electrode
02/04/2010US20100030046 Subcutaneous Glucose Electrode
02/04/2010US20100030044 Subcutaneous Glucose Electrode
02/04/2010US20100029922 Platelet Derived Growth Factor (PDGF) Nucleic Acid Ligand Complexes
02/04/2010US20100029773 Systematic identification of new anti-prion drugs by high-throughput screening based on scanning for intensely fluorescent targets (sift)
02/04/2010US20100029748 Metastasis Promoting Genes and Proteins
02/04/2010US20100029724 Screening method
02/04/2010US20100029716 Novel 1,2,3,4- tetrahydroquinoline derivatives
02/04/2010US20100029702 Method For Identification of Compound Having Anti-Anxiety Effect
02/04/2010US20100029683 Methods for regulating cell mitosis by inhibiting serine/threonine phosphateses
02/04/2010US20100029676 T315a and f317i mutations of bcr-abl kinase domain
02/04/2010US20100029613 Treatment and prevention of epilepsy
02/04/2010US20100029610 Heteroaryl Compounds and Uses Thereof
02/04/2010US20100029580 Method for Diagnosing Non-Small Cell Lung Carcinoma
02/04/2010US20100029576 Diazoxide for the treatment of Friedreich's Ataxia
02/04/2010US20100029561 Ameliorating agent for insulin resistance
02/04/2010US20100029560 Compositions and methods for diagnosing, treating, and preventing prostate conditions
02/04/2010US20100029559 Method for achieving desired glial growth factor 2 plasma levels
02/04/2010US20100029558 Alpha1 proteinase inhibitor peptides methods and use
02/04/2010US20100029510 siRNA targeting survivin
02/04/2010US20100029509 Novel methods
02/04/2010US20100029508 Nanochannel arrays and their preparation and use for high throughput macromolecular analysis
02/04/2010US20100029504 Detecting pax2 for the diagnosis of breast cancer
02/04/2010US20100029501 Method of identifying micro-rna targets
02/04/2010US20100029500 Oligonucleotide arrays to monitor gene expression and methods for making and using same
02/04/2010US20100029494 Macromolecular Nucleotide Compounds And Methods For Using The Same
1 ... 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 ... 3003